Cambridge, United Kingdom
ExpressionEdits, founded in 2021, is a promising startup in the AI and Biotechnology industries. Headquartered in the United Kingdom, the company is fundamentally redefining genetic design with its slogan, "building biology like nature."
By focusing on the precise application of genetic grammar in transgenic design, ExpressionEdits is enabling the creation of previously inaccessible proteins. Their innovative approach is encapsulated in their description: "Getting genetic syntax right," which positions them as a pioneering force in genetic technology.
The company's robust potential attracted a $13.00M Seed Round investment on 29 May 2024. This round was led by notable investors including Blue Yard Capital, Octopus Ventures, Redalpine, Wilbe | Home for Scientist Leaders, Amino Collective, Acequia Capital (AceCap), and Hawktail Management. This diverse group of backers underscores the strong confidence in ExpressionEdits' groundbreaking technological innovations.
